These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22045701)

  • 21. Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells.
    Ma JF; Nonn L; Campbell MJ; Hewison M; Feldman D; Peehl DM
    Mol Cell Endocrinol; 2004 Jun; 221(1-2):67-74. PubMed ID: 15223133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia.
    Cotant CL; Rao PS
    Am J Kidney Dis; 2007 Dec; 50(6):1033-6. PubMed ID: 18037105
    [No Abstract]   [Full Text] [Related]  

  • 23. Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk.
    Yin L; Raum E; Haug U; Arndt V; Brenner H
    Cancer Epidemiol; 2009 Dec; 33(6):435-45. PubMed ID: 19939760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D and prostate cancer.
    Feldman D; Zhao XY; Krishnan AV
    Endocrinology; 2000 Jan; 141(1):5-9. PubMed ID: 10614617
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study.
    Brändstedt J; Almquist M; Manjer J; Malm J
    Cancer Causes Control; 2012 Aug; 23(8):1377-85. PubMed ID: 22706676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer.
    Varsavsky M; Reyes-García R; Cortés-Berdonces M; García-Martin A; Rozas-Moreno P; Muñoz-Torres M
    Endocrinol Nutr; 2011 Nov; 58(9):487-91. PubMed ID: 22014882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
    Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Ahn J; Albanes D; Peters U; Schatzkin A; Lim U; Freedman M; Chatterjee N; Andriole GL; Leitzmann MF; Hayes RB;
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2623-30. PubMed ID: 18086766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to optimizing vitamin D therapy in prostate cancer.
    Schwartz GG
    J Urol; 2011 Apr; 185(4):1179-80. PubMed ID: 21334691
    [No Abstract]   [Full Text] [Related]  

  • 30. Correspondence re: E. H. Corder et al., Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol., Biomarkers & Prev., 2: 467-472, 1993.
    Schwartz GG
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):183-4. PubMed ID: 8049642
    [No Abstract]   [Full Text] [Related]  

  • 31. Baseline serum 25-hydroxyvitamin d levels in men undergoing radical prostatectomy: is there an association with adverse pathologic features?
    Berg WT; Shapiro EY; Rothberg MB; Bergman A; Scarberry K; Wambi C; Patel T; Badani KK
    Clin Genitourin Cancer; 2014 Oct; 12(5):330-4. PubMed ID: 24680790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D deficiency promotes prostate cancer growth in bone.
    Zheng Y; Zhou H; Ooi LL; Snir AD; Dunstan CR; Seibel MJ
    Prostate; 2011 Jun; 71(9):1012-21. PubMed ID: 21541977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of calcium intake and incident and fatal prostate cancer.
    Giovannucci E; Liu Y; Stampfer MJ; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):203-10. PubMed ID: 16492906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D in the prevention and treatment of prostate cancer.
    Konety BR; Johnson CS; Trump DL; Getzenberg RH
    Semin Urol Oncol; 1999 May; 17(2):77-84. PubMed ID: 10332920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Calcium plus vitamin D supplementation and the risk of breast cancer.
    Olsen A; Egeberg R; Tjønneland A
    J Natl Cancer Inst; 2009 May; 101(9):690; author reply 690-1. PubMed ID: 19401545
    [No Abstract]   [Full Text] [Related]  

  • 37. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
    Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P
    Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.
    Dambal S; Giangreco AA; Acosta AM; Fairchild A; Richards Z; Deaton R; Wagner D; Vieth R; Gann PH; Kajdacsy-Balla A; Van der Kwast T; Nonn L
    J Steroid Biochem Mol Biol; 2017 Mar; 167():192-202. PubMed ID: 28089917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vitamin D and cancer].
    Yamana K; Saito H; Takenouchi K; Azuma Y; Ishizuka S
    Clin Calcium; 2006 Jul; 16(7):1147-53. PubMed ID: 16816475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
    Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
    Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.